BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 6:27:00 PM | Browse: 934 | Download: 797
Publication Name World Journal of Stem Cells
Manuscript ID 7287
Country United States
Received
2013-11-12 15:27
Peer-Review Started
2013-11-13 14:17
To Make the First Decision
2013-12-25 18:06
Return for Revision
2013-12-31 14:35
Revised
2014-01-03 04:58
Second Decision
2014-03-17 14:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-17 14:51
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-04-18 20:18
Publish the Manuscript Online
2014-04-28 14:14
ISSN 1948-0210 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions
Manuscript Source Invited Manuscript
All Author List Abraham S Kanate, Marcelo C Pasquini, Parameswaran N Hari and Mehdi Hamadani
Funding Agency and Grant Number
Corresponding Author Mehdi Hamadani, MD, Associate Professor of Medicine, Division of Hematology and Oncology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, United States. mhamadani@mcw.edu
Key Words Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation; Reduced intensity conditioning; Myeloablative conditioning; Haploidentical; Umbilical cord blood
Core Tip Acute myeloid leukemia (AML) represents a heterogeneous group of high-grade myeloid neoplasms of the elderly with variable outcomes. We discuss the role of allo-hematopoietic cell transplantation (HCT) in AML patients stratified by cytogenetic- and molecular-risk in first complete remission, as well as allo-HCT as an option in relapsed/refractory AML.
Publish Date 2014-04-28 14:14
Citation Kanate AS, Pasquini MC, Hari PN, Hamadani M. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World J Stem Cells 2014; 6(2): 69-81
URL http://www.wjgnet.com/1948-0210/full/v6/i2/69.htm
DOI http://dx.doi.org/10.4252/wjsc.v6.i2.69
Full Article (PDF) WJSC-6-69.pdf
Full Article (Word) WJSC-6-69.doc
Manuscript File 7287-Review.docx
Answering Reviewers 7287-Answering reviewers.pdf
Copyright License Agreement 7287-Copyright assignment.pdf
Peer-review Report 7287-Peer reviews.pdf
Scientific Editor Work List 7287-Scientific editor work list.doc